Developing an m5C regulator–mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer

BACKGROUND: Currently, a very small number of patients with colorectal cancer (CRC) respond to immune checkpoint inhibitor (ICI) treatment. Therefore, there is an urgent need to investigate effective biomarkers to determine the responsiveness to ICI treatment. Recently, aberrant 5-methylcytosine (m(...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rixin, Gan, Wenqiang, Zong, Jinbao, Hou, Yufang, Zhou, Mingxuan, Yan, Zheng, Li, Tiegang, Lv, Silin, Zeng, Zifan, Wang, Weiqi, Zhang, Fang, Yang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992543/
https://www.ncbi.nlm.nih.gov/pubmed/36911744
http://dx.doi.org/10.3389/fimmu.2023.1054700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992543/
https://www.ncbi.nlm.nih.gov/pubmed/36911744
http://dx.doi.org/10.3389/fimmu.2023.1054700

Ejemplares similares